Table Of Contents
1 Executive Summary
2 Epidemiology
2.1 Total Diabetes Patients
2.2 Patients by Gender
2.3 Patients by Age Group
2.4 Patients by Region
3 Market Dynamics
3.1 Diabetes Market
3.1.1 Current Trends (2005–2010)
3.1.2 Market Forecast (2011-2016)
3.2 Insulin Market
3.2.1 Current Trends (2005-2010)
3.2.1.1 Market by Class
3.2.1.2 Market by Molecule
3.2.1.3 Top Players
3.2.1.4 Top Drugs
3.2.2 Market Forecast (2011-2016)
3.3 Oral Antidiabetics
3.3.1 Current Trends (2005-2010)
3.3.1.1 Market by Class
3.3.1.2 Top Players
3.3.1.3 Top Drugs
3.3.2 Market Forecast (2011-2016)
List of Figures
Figure 2 1: Turkey: Number of Diabetes Patients* (000’s), 2010, 2015, 2020, 2025 & 2030
Figure 2 2: Turkey: Breakup of Diabetes Patients* by Gender (000’s), 2010, 2015, 2020, 2025 & 2030
Figure 2 3: Turkey: Breakup of Diabetes Patients* by Gender (in %), 2010, 2015, 2020, 2025 & 2030
Figure 2 4: Turkey: Breakup of Diabetes Patients* by Age Group (000’s), 2010, 2015, 2020, 2025 & 2030
Figure 2 5: Turkey: Breakup of Diabetes Patients* by Age Group (in %) 2010, 2015, 2020, 2025 & 2030
Figure 2 4: Turkey: Breakup of Diabetes Patients* by Region (000’s), 2010, 2015, 2020, 2025 & 2030
Figure 2 6: Turkey: Breakup of Diabetes Patients* by Region, (in %), 2010, 2015, 2020, 2025 & 2030
Figure 3 1: Turkey: Diabetes Market (in Million US$), 2005-2010
Figure 3 2: Turkey: Diabetes Market: Breakup of Insulin and Oral Antidiabetics (in %), 2005-2010
Figure 3 3: Turkey: Diabetes Market Forecast (in Million US$), 2011-2016
Figure 3 4: Turkey: Diabetes Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2016
Figure 3 5: Turkey: Insulin Market (in Million US$), 2005-2010
Figure 3 6: Turkey: Insulin Market: Share by Class (in %), 2005-2010
Figure 3 7: Turkey: Insulin Market: Share by Molecule (in %), 2005-2010
Figure 3 8: Turkey: Insulin Market: Share of Key Players (in %), 2005-2010
Figure 3 9: Turkey: Insulin Market: Share of Key Drugs (in %), 2005-2010
Figure 3 10: Turkey: Insulin Market Forecast (in Million US$), 2011-2016
Figure 3 11: Turkey: Oral Antidiabetics Market (in Million US$), 2005-2010
Figure 3 12: Turkey: Oral Antidiabetics Market: Share by Class (in %), 2005-2010
Figure 3 13: Turkey: Oral Antidiabetics Market: Share of Key Players (in %), 2005-2010
Figure 3 14: Turkey: Oral Antidiabetics Market: Share of Key Drugs (in %), 2005-2010
Figure 3 15: Turkey: Oral Antidiabetics Market Forecast (in Million US$), 2011-2016
Figure 3 16: Turkey: Oral Antidiabetics Market: Share Forecast by Class (in %), 2010, 2013 & 2016
List of Tables
Table 1 1: Turkey: Oral Antidiabetics & Insulin Market Definitions
Table 3 1: Turkey: Insulin Market: Sales by Class (in Million US$), 2005-2010
Table 3 2: Turkey: Insulin Market: Sales by Molecule (in Million US$), 2005-2010
Table 3 3: Turkey: Insulin Market: Sales of Key Players (in Million US$), 2005-2010
Table 3 4: Turkey: Insulin Market: Sales of Key Drugs (in Million US$), 2005-2010
Table 3 5: Turkey: Oral Antidiabetics Market: Sales by Class (in Million US$), 2005-2010
Table 3 6: Turkey: Oral Antidiabetics Market: Sales of Key Players (in Million US$), 2005-2010
Table 3 7: Turkey: Oral Antidiabetics Market: Sales of Key Drugs (in Million US$), 2005-2010
Table 3 8: Turkey: Oral Antidiabetics Market: Sales Forecast by Class (in Million US$), 2010, 2013 & 2016
Table 3 9: Turkey: Oral Antidiabetics Market: New Drug Launches (2011-2016)